| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |